Abstract

BackgroundInfluenza viruses show a significant capacity to evade host immunity; this is manifest both as large occasional jumps in the antigenic phenotype of viral surface molecules and in gradual antigenic changes leading to annual influenza epidemics in humans. Recent mouse studies show that avidity for host cells can play an important role in polyclonal antibody escape, and further that electrostatic charge of the hemagglutinin glycoprotein can contribute to such avidity.Methodology/Principal FindingsWe test the role of glycoprotein charge on sequence data from the three major subtypes of influenza A in humans, using a simple method of calculating net glycoprotein charge. Of all subtypes, H3N2 in humans shows a striking pattern of increasing positive charge since its introduction in 1968. Notably, this trend applies to both hemagglutinin and neuraminidase glycoproteins. In the late 1980s hemagglutinin charge reached a plateau, while neuraminidase charge started to decline. We identify key groups of amino acid sites involved in this charge trend.Conclusions/SignificanceTo our knowledge these are the first indications that, for human H3N2, net glycoprotein charge covaries strongly with antigenic drift on a global scale. Further work is needed to elucidate how such charge interacts with other immune escape mechanisms, such as glycosylation, and we discuss important questions arising for future study.

Highlights

  • The influenza A virus is a prominent example of a pathogen capable of adapting to evade host immunity [1,2], with profound implications for epidemiology and control

  • We ask the following questions: considering epidemic influenza in humans, is there any indication for the role of electrostatic charge in viral evolution? How might these relate to observed patterns of antigenic drift, most notably for the subtype H3N2?

  • Recent experiments show that the enhancement of avidity for host cells is a potentially potent mechanism [10]

Read more

Summary

Introduction

The influenza A virus is a prominent example of a pathogen capable of adapting to evade host immunity [1,2], with profound implications for epidemiology and control. Immunity to influenza is mediated predominantly by neutralizing antibodies raised against two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA) [4]. Glycosylation - the posttranscriptional acquisition of carbohydrate side-chains - can have the additional effect of ‘masking’ epitopes from antibody recognition [8], but at a cost: heavily glycosylated viruses are more susceptible to capture by the host innate immune system [9]. Influenza viruses show a significant capacity to evade host immunity; this is manifest both as large occasional jumps in the antigenic phenotype of viral surface molecules and in gradual antigenic changes leading to annual influenza epidemics in humans. Recent mouse studies show that avidity for host cells can play an important role in polyclonal antibody escape, and further that electrostatic charge of the hemagglutinin glycoprotein can contribute to such avidity

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call